Image Description (Image01)
Hicon Solution
Product Images NDC 65174-880
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Hicon (NDC 65174-880). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Jubilant Draximage Inc., Dba Jubilant Radiopharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image Description (Image02)
Image Description (Image03)
Image Description (Image04)
Image Description (Image05)
Label 1
HICON® Sodium Iodide 131 Solution, USP is a radioactive pharmaceutical solution with a concentration of 1,000 milliCurie per milliliter. The lot number is 2270252-0, and it expires on April 4, 2022. Jubilant DraxImage Inc. produces it. The solution is labeled with the number 50 and 511370.*
Label 2
This is a description of a radioactive drug labeled Lot: 2270252-2 502880-2 NDC 65174-880-25, with a total activity of 250 mCi HICON® 5, made from Sodium iodide 131 solution for oral use. It is recommended to be stored between 2 °C and 36°F and should not be used after 04/APR/2022. The drug is manufactured by RxOnly, which is owned by Jubilant DraxImage Inc. and Jubilant Radiopharman, both based in Kirkland, Quebec, Canada. There is no information provided about how the drug should be used or for which medical conditions it is indicated.*
Label 3
This text appears to be a description of a radioactive substance, specifically Sodium Iodide in solution form. The lot number, NDC number, total activity, volume, concentration, calibration, recommended dose, and storage conditions are all provided. The substance is manufactured by a company called Jubilant Draximage Inc. and is intended for therapeutic use with oral administration. The text also includes cautionary information about the substance being radioactive and it is only available for use by prescription.*
Label 6
This is a description of a radioactive solution of Sodium Iodide (NaI) in a volume of 1.00 mL, with a total activity of 1,000 mCi and a concentration of 1,000 mCi/mL. The solution has a calibration date of 26/MAR/2022 and an expiration date of 04/APR/2022, and it is intended for therapeutic oral use. The specific activity is reported as "no carrier added," and the cautionary label indicates that it is a radioactive substance. The recommended dose and prescribing information are not given, and it is also not clear what the purpose or application of the solution is.*
Logo
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
